1-Hydroxypropan-2-yl 4-hydroxybenzoate | 438537-46-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-Hydroxypropan-2-yl 4-hydroxybenzoate
• CAS: 438537-46-3
• 化学式: C₁₀H₁₂O₄
• 分子量: 196.2
• InChiKey: UZAWKCIZDTWSPX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• METHODS OF REDUCING THE PROLIFERATION AND VIABILITY OF MICROBIAL AGENTS
  申请人：Henry William

  公开号：US20100197621A1

  公开（公告）日：2010-08-05

  The invention relates to formulations of an antimicrobial agent, a lipid, and optionally a surfactant, and uses thereof for reducing the proliferation and viability of microbial agents.
• METHODS OF REDUCING THE PROLIFERATION AND VIABLILITY OF MICROBIAL AGENTS
  申请人：Henry William

  公开号：US20120245107A1

  公开（公告）日：2012-09-27

  The invention relates to formulations of an antimicrobial agent, a lipid, and optionally a surfactant, and uses thereof for reducing the proliferation and viability of microbial agents.
• [EN] METHODS OF REDUCING THE PROLIFERATION AND VIABILITY OF MICROBIAL AGENTS<br/>[FR] MÉTHODES DE RÉDUCTION DE LA PROLIFÉRATION ET DE LA VIABILITÉ D'AGENTS MICROBIENS
  申请人：TDT LTD

  公开号：WO2010090654A1

  公开（公告）日：2010-08-12

  The invention relates to formulations of an antimicrobial agent, a lipid, and optionally a surfactant, and uses thereof for reducing the proliferation and viability of microbial agents.
• [EN] LITHIUM TREATMENT FOR MICROBIAL INFECTIONS<br/>[FR] TRAITEMENT AU LITHIUM POUR INFECTIONS MICROBIENNES
  申请人：FOLLICA INC

  公开号：WO2012125941A1

  公开（公告）日：2012-09-20

  The invention relates to lithium treatments for treating microbial infections in human subjects. Uses of compositions containing compounds that liberate lithium ions are described, including adjuvants and devices for administration. The lithium treatment(s) can be used in combination with other treatments, such as mupirocin, for treating microbial infections. The combination treatment(s) may be administered concurrently with, or before and/or after the lithium treatment. The invention also relates to lithium treatments for scar revision and wound healing in human subjects. The invention also relates to dermabrasion treatments for skin conditions and novel dermabrasion tips for carrying out such treatments.
• [EN] COMPOSITIONS AND METHODS FOR REDUCING THE PROLIFERATION AND VIABILITY OF MICROBIAL AGENTS<br/>[FR] COMPOSITIONS ET PROCÉDÉS POUR LA RÉDUCTION DE LA PROLIFÉRATION ET DE LA VIABILITÉ D'AGENTS MICROBIENS
  申请人：TARGETED DELIVERY TECHNOLOGIES LTD

  公开号：WO2013057208A1

  公开（公告）日：2013-04-25

  The disclosure relates to formulations of an antimicrobial agent, a lipid, and optionally a surfactant, and uses thereof for reducing the proliferation and viability of microbial agents. In certain embodiments the disclosure relates to a single composition that includes two antimicrobial agents and method of using such single compostions.